Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01788488 · ClinicalTrials.gov registry record · NA

Procalcitonin Use in Pneumonia Patients in the Critical Care Setting

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
134
Enrollment target

NCT01788488: Completed NA study, sponsored by Mayo Clinic.

NCT01788488 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 134 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01788488, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
134 participants
Enrollment target

Study Summary

The goal of the study is to determine the impact of procalcitonin (PCT)-guided therapy on duration of antibiotic therapy in critical care unit (CCU) patients with suspected pneumonia at Mayo Clinic Health System Eau Claire.

Primary Outcome

Participants will be followed for the entire time they are on antibiotics to treat pneumonia, an expected average of 30 total antibiotic days.

Interventions

  • OTHER Use of procalcitonin as biomarker to guide therapy

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2013-02
Est. Completion 2013-06
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT01788488 record still lists

NCT01788488 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which Use of procalcitonin as biomarker to guide therapy is the first listed.

NCT01788488 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01788488 about?

NCT01788488 is a clinical study titled "Procalcitonin Use in Pneumonia Patients in the Critical Care Setting". The goal of the study is to determine the impact of procalcitonin (PCT)-guided therapy on duration of antibiotic therapy in critical care unit (CCU) patients with suspected pneumonia at Mayo Clinic Health System Eau Claire.

What is the current status of trial NCT01788488?

This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2013-02. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01788488?

The interventions under investigation include: Use of procalcitonin as biomarker to guide therapy (OTHER).

Who is sponsoring clinical trial NCT01788488?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01788488's enrollment target sits among peer trials

134 728th of 2000 higher than 1,272 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02469662 · 134 participants · NA

    Clinical Outcomes Study of the Nexel Total Elbow

  • NCT03110822 · 134 participants · Phase 1

    A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

  • NCT04678648 · 134 participants · Phase 1

    A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

  • NCT05264857 · 134 participants · NA

    Decision Aid and Thyroid Nodules Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01788488, the US trial registry maintained by the National Library of Medicine. NCT01788488 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.